Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-21-007919
Filing Date
2021-04-28
Accepted
2021-04-28 16:01:43
Documents
1
Period of Report
2021-06-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2021proxy.htm DEF 14A 581867
  Complete submission text file 0001628280-21-007919.txt   583143
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35558 | Film No.: 21864122
SIC: 2836 Biological Products, (No Diagnostic Substances)